BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18843182)

  • 1. Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment.
    Thomann PA; Roth AS; Dos Santos V; Toro P; Essig M; Schröder J
    Dement Geriatr Cogn Disord; 2008; 26(4):300-5. PubMed ID: 18843182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
    Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
    J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study.
    Pennanen C; Testa C; Boccardi M; Laakso MP; Hallikainen M; Helkala EL; Hänninen T; Kivipelto M; Könönen M; Nissinen A; Tervo S; Vanhanen M; Vanninen R; Frisoni GB; Soininen H
    Dement Geriatr Cogn Disord; 2006; 22(1):60-6. PubMed ID: 16682795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
    Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H
    Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
    Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study.
    Babiloni C; Benussi L; Binetti G; Cassetta E; Dal Forno G; Del Percio C; Ferreri F; Ferri R; Frisoni G; Ghidoni R; Miniussi C; Rodriguez G; Romani GL; Squitti R; Ventriglia MC; Rossini PM
    Ann Neurol; 2006 Feb; 59(2):323-34. PubMed ID: 16358334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele.
    Wishart HA; Saykin AJ; McAllister TW; Rabin LA; McDonald BC; Flashman LA; Roth RM; Mamourian AC; Tsongalis GJ; Rhodes CH
    Neurology; 2006 Oct; 67(7):1221-4. PubMed ID: 17030756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
    De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
    Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE I/D polymorphism affects cognitive function and gray-matter volume in amnestic mild cognitive impairment.
    Zhang Z; Deng L; Bai F; Shi Y; Yu H; Yuan Y; Jiang T; Jia J; Zhang Z
    Behav Brain Res; 2011 Mar; 218(1):114-20. PubMed ID: 21108975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia.
    Bartzokis G; Lu PH; Geschwind DH; Edwards N; Mintz J; Cummings JL
    Arch Gen Psychiatry; 2006 Jan; 63(1):63-72. PubMed ID: 16389198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?
    Persson J; Lind J; Larsson A; Ingvar M; Cruts M; Van Broeckhoven C; Adolfsson R; Nilsson LG; Nyberg L
    Neurology; 2006 Apr; 66(7):1029-33. PubMed ID: 16606914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer's disease.
    Thomann PA; Toro P; Dos Santos V; Essig M; Schröder J
    Brain Cogn; 2008 Jun; 67(1):88-93. PubMed ID: 18215449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.